Safety, tolerability and pharmacokinetics/-dynamics of the anti-adrenomedullin antibody Adrecizumab: A first in man study

Authors
Category Primary study
ConferenceIntensive Care Medicine Experimental
Year 2017
This article has no abstract
Epistemonikos ID: 3e0e23917c5dc16da3190bc2908d2025a4ce0faf
First added on: Apr 29, 2026